Research ArticleCARDIOVASCULAR
Differentiation of Arrhythmia Risk of the Antibacterials Moxifloxacin, Erythromycin, and Telithromycin Based on Analysis of Monophasic Action Potential Duration Alternans and Cardiac Instability
Todd Wisialowski, Kimberly Crimin, Juntyma Engtrakul, John O'Donnell, Bernard Fermini and Anthony A. Fossa
Journal of Pharmacology and Experimental Therapeutics July 2006, 318 (1) 352-359; DOI: https://doi.org/10.1124/jpet.106.101881
Todd Wisialowski
Kimberly Crimin
Juntyma Engtrakul
John O'Donnell
Bernard Fermini
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleCARDIOVASCULAR
Differentiation of Arrhythmia Risk of the Antibacterials Moxifloxacin, Erythromycin, and Telithromycin Based on Analysis of Monophasic Action Potential Duration Alternans and Cardiac Instability
Todd Wisialowski, Kimberly Crimin, Juntyma Engtrakul, John O'Donnell, Bernard Fermini and Anthony A. Fossa
Journal of Pharmacology and Experimental Therapeutics July 1, 2006, 318 (1) 352-359; DOI: https://doi.org/10.1124/jpet.106.101881
Research ArticleCARDIOVASCULAR
Differentiation of Arrhythmia Risk of the Antibacterials Moxifloxacin, Erythromycin, and Telithromycin Based on Analysis of Monophasic Action Potential Duration Alternans and Cardiac Instability
Todd Wisialowski, Kimberly Crimin, Juntyma Engtrakul, John O'Donnell, Bernard Fermini and Anthony A. Fossa
Journal of Pharmacology and Experimental Therapeutics July 1, 2006, 318 (1) 352-359; DOI: https://doi.org/10.1124/jpet.106.101881
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement